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SUMMARY 
Cardiac stem/progenitor cells hold great potential for regenerative therapies, however, the 
mechanisms regulating their expansion and differentiation remain insufficiently defined. Here we 
show that the multi-adaptor protein Ldb1 is a central regulator of cardiac progenitor cell 
differentiation and second heart field (SHF) development. Mechanistically, we demonstrate that 
Ldb1 binds to the key regulator of SHF progenitors Isl1 and protects it from proteasomal 
degradation. Furthermore, the Isl1/Ldb1 complex promotes long-range promoter-enhancer 
interactions at the loci of the core cardiac transcription factors Mef2c and Hand2. Chromosome 
conformation capture followed by sequencing identified surprisingly specific, Ldb1-mediated 
interactions of the Isl1/Ldb1 responsive Mef2c anterior heart field enhancer with genes which 
play key roles in cardiac progenitor cell function and cardiovascular development. Importantly, 
the expression of these genes was downregulated upon Ldb1 depletion and Isl1/Ldb1 
haplodeficiency. In conclusion, the Isl1/Ldb1 complex orchestrates a network for heart-specific 
transcriptional regulation and coordination in three-dimensional space during cardiogenesis.  
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INTRODUCTION 
Heart failure is the leading cause of morbidity and mortality worldwide. Due to the limited 
regenerative capacity of the human heart, cardiomyocytes lost during heart injury are substituted 
by a non-contractile fibrotic scar tissue, resulting in decreased cardiac function and ultimately 
heart failure. A number of cardiac regenerative strategies have been proposed of which stem/ 
progenitor cells hold great promise for heart repair (Aguirre et al., 2013; Hansson et al., 2009; 
Laflamme and Murry, 2011). Knowledge accumulated from developmental studies have 
significantly improved the methods for in vitro cardiac differentiation from embryonic stem (ES) 
cells and studies utilizing ES differentiation have brought further insights in the regulatory 
networks integrating multiple transcription factors and signaling molecules, which strictly control 
the distinct steps of cardiogenesis. However, the current limitations for the use of stem/ 
progenitor cells in regenerative medicine, e.g. linked to their expansion, differentiation efficiency 
and functional integration, call for a more complete understanding of the mechanisms driving 
cardiovascular lineage commitment, expansion and differentiation. 
During embryogenesis the heart is generated by a common progenitor at gastrulation that 
segregates into two distinct populations, termed first and second heart fields. The first heart field 
(FHF), fuses at the midline and differentiates into the myocardium of the heart tube. After the 
initial heart tube formation, the heart tube grows by addition of Isl1-positive second heart field 
(SHF) progenitor cells to its anterior and venous poles (Cai et al., 2003; Evans et al., 2010; 
Vincent and Buckingham, 2010). Studies in different model systems revealed the crucial function 
of the LIM-homeodomain transcription factor Isl1 in heart morphogenesis (Cai et al., 2003; de 
Pater et al., 2009; Witzel et al., 2012). Isl1-deficient mouse embryos lack the right ventricle and 
the outflow tract, both structures derived from the SHF, as Isl1 is required for the proliferation, 
survival, and migration of these cells into the forming heart (Cai et al., 2003). Importantly, the 
Isl1-positive cardiovascular progenitors are multipotent and can differentiate into all three 
cardiovascular lineages: cardiomyocytes, smooth muscle cells and endothelial cells (Moretti et 
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al., 2006). Moreover, Isl1 is required for the differentiation of these cells into the cardiomyocyte 
and smooth muscle lineage (Kwon et al., 2009), but the mechanisms underlying its function are 
poorly understood. 
The acquisition of cellular identity involves genome reorganization and a coordinated series of 
large-scale transcriptional changes (Dixon et al., 2015; Dixon et al., 2012; Gorkin et al., 2014; 
Peric-Hupkes et al., 2010). Using chromosome conformation capture (3C) assays and 3C-based 
technologies (de Wit and de Laat, 2012; Dekker et al., 2002) recent studies have suggested that 
CTCF together with Cohesin might be involved in general formation of chromatin structures by 
promoting constitutive long-range DNA interactions, whereas specific transcription factors, their 
co-factors together with CTCF, Cohesin and the Mediator complex might be involved in 
controlling locus-specific looping interactions and lineage-specific transcription (Kagey et al., 
2010; Phillips-Cremins et al., 2013; Shen et al., 2012). In ES cells for example the binding of the 
key pluripotency transcription factors Oct4, Sox2, and Nanog was shown to be a key 
determinant of genome organization, as regions with a high density of binding sites for these 
factors tend to colocalize in nuclear space (de Wit et al., 2013; Denholtz et al., 2013). Another 
example for a cofactor involved in promoting locus-specific and cell type-specific interactions is 
Ldb1 (Deng et al., 2012; Morcillo et al., 1997; Soler et al., 2010; Song et al., 2007). Ldb1 directly 
binds to LIM domain- and Otx proteins and is found in large complexes with bHLH and GATA 
transcription factors (Bach et al., 1997; Jurata et al., 1998; Meier et al., 2006; Tripic et al., 2009). 
By bringing together distinct transcription factors and their coregulators, associated with different 
transcriptional control elements, Ldb1 facilitates long range promoter-enhancer interactions and 
regulates cell-type specific expression patterns (Deng et al., 2012; Morcillo et al., 1997; Soler et 
al., 2010; Song et al., 2007).  
Here we show that Ldb1 is a multifunctional regulator of SHF development and cardiac 
differentiation. We show that the importance of Ldb1 for SHF development is two-fold. On the 
one hand, Ldb1 binds to Isl1 and protects it from proteasomal degradation, as a consequence of 
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which Ldb1-deficiency leads to an almost complete loss of Isl1+ cardiovascular progenitor cells. 
On the other hand, the Isl1/Ldb1 complex promotes long-range promoter enhancer interactions 
at the loci of the key developmental regulators of cardiogenesis Mef2c and Hand2. Using 3C-seq 
we identified specific Ldb1-mediated interactions of the Mef2c AHF enhancer with genes which 
play key roles in cardiovascular development as well as cell fate commitment. Moreover, Ldb1-
deficient cells and Isl1/Ldb1 haplodeficient embryos, which show various cardiac anomalies, 
show a dramatically decreased expression of genes associated with the AHF enhancer and 
overexpression of Isl1 and Ldb1 strongly promoted their expression. Thus, the Isl1/Ldb1 
complex plays a central role in transcriptional regulation and chromatin organization in three-
dimensional space during cardiac differentiation and SHF development. 
 
 
RESULTS  
Ldb1 regulates cardiac progenitor cell differentiation and second heart field development 
The LIM domain transcription factor Isl1 is required for the proliferation, survival, and 
differentiation of SHF cardiac progenitor cells, as a consequence of which Isl1-deficient mouse 
embryos lack the right ventricle and the outflow tract, both structures derived from the SHF (Cai 
et al., 2003). Similarly, Ldb1 deficiency results in early embryonic lethality with a series of 
developmental defects, including lack of heart formation (Mukhopadhyay et al., 2003). 
Therefore, we reasoned that Isl1 and Ldb1 might work in concert to regulate cardiac progenitor 
cell function. To elucidate the functional role of Ldb1 in cardiogenesis we first utilized wild-type 
and Ldb1 knockout (Ldb1-/-) ES cells and differentiated them in embryoid bodies (EBs) to 
facilitate the generation and differentiation of cardiac progenitor cells (Figure 1A). Importantly, in 
contrast to control EBs, which started beating already at day 6 (d6), the EBs differentiated from 
Ldb1-/- cells showed no beating foci (Figure 1B). Consistent with this, the expression of 
cardiomyocyte marker genes (Mlc2a, Mlc2v, Tnnt2) was dramatically reduced (Figure 1C). 
Additionally, the expression of endothelial markers (Flk1, CD31) was also downregulated (Figure 
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1C). By contrast, the expression of smooth muscle genes (SM-actin, SM-22) was upregulated 
(Figure 1C), suggesting that Ldb1 is important for proper differentiation into cardiomyocyte and 
endothelial cell lineages. Next, we analyzed whether Ldb1-deficiency affects early 
developmental decisions, e.g. mesoderm induction, which could subsequently affect cardiac 
progenitor cell differentiation. Real-time PCR analysis for mesoderm (Eomes, Bry) and cardiac 
mesoderm markers (Mesp1, Mesp2) showed no significant difference in the peak expression 
level between control and Ldb1-deficient EBs, however the peak expression of these markers 
was delayed by one day (Figure 1D). Next, we analyzed the expression of pan-cardiac genes 
and genes specifically expressed in the FHF and the SHF (Figure 1E). Interestingly, while the 
expression of Isl1, Tbx1, Hand2 and Fgf10, which play important roles in the SHF, and the pan-
cardiac genes Nkx2-5 and Mef2c was significantly downregulated at d4, d5 and d6, genes 
expressed in the FHF (Tbx5, Hand1, Gata4) showed no significant change (Figure 1E, data not 
shown), suggesting a role of Ldb1 in the regulation of SHF progenitor cells. To further 
investigate the role of Ldb1 in SHF development, we ablated Ldb1 using an Isl1-Cre driver line 
that results in Cre recombination in SHF progenitor cells (Cai et al., 2003). Isl1-Cre:Ldb1 flox/flox 
embryos died by E10.5 with shortened outflow tract and small right ventricle (Figure 1F-G, 
Figure S1A). Furthermore, we observed significant downregulation of cardiomyocyte marker 
genes in the right ventricle and the outflow tract, both structures derived from the SHF, whereas 
no change in these genes was observed in the left ventricle, derived mainly from the first heart 
field (Figure 1H, Figure S1B). Taken together, these results confirm that Ldb1 is essential for 
SHF progenitor cell differentiation and cardiac development.  
Ldb1 protects Isl1 from proteasomal degradation 
To gain a better understanding of the mechanisms underlying Ldb1 function in cardiogenesis, 
we analyzed cardiovascular progenitors in more detail. FACS analysis for Flk-1 and PdgfR-α 
demonstrated no significant differences in early cardiovascular progenitor numbers (Figure 2A). 
Interestingly, although Isl1 mRNA levels were only slightly reduced in EBs differentiated from 
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Ldb1-/- ES cells at all time-points that we analyzed (Figure 1E, 2B), Isl1+ cells were virtually 
absent in Ldb1-/- EBs (Figure 2C). Western blot analysis confirmed the dramatically reduced 
levels of Isl1 in Ldb1-deficient EBs (Figure 2D). The absence of Isl1 protein, without pronounced 
changes of Isl1 mRNA levels, suggested that Isl1 is regulated at the protein level. Pull down of 
Isl1 detected slower-migrating ubiquitinated forms of Isl1, that were increased in the presence of 
the proteasomal inhibitor MG-132, indicating that Isl1 is targeted for proteasomal degradation 
(Figure 2E). To analyze this in more detail, we transfected HEK293T cells with Isl1 deletion 
constructs lacking the LIM1 and/or LIM2 domain and treated them with MG-132. The levels of 
the truncated proteins lacking LIM2 or containing only the homeodomain were relatively 
unchanged, but the levels of the Isl1 protein lacking LIM1 were significantly increased upon MG-
132 treatment, suggesting that LIM2 is subjected to ubiquitination (Figure 2F). Next we analyzed 
whether binding of Ldb1 to Isl1 might protect it from proteasomal degradation, similarly to Lhx3 
(Gungor et al., 2007). To assess this possibility we transfected HEK293T cells with an Isl1 
plasmid alone or together with increasing amounts of Ldb1 or Ldb1 deletion constructs and 
constant amounts of GFP, which served as a control for transfection efficiency (Figure 2G). 
Importantly, increasing levels of Ldb1 and truncated Ldb1 protein lacking the dimerization 
domain (DN-Ldb1) led to a significant increase of Isl1 protein levels but did not change the levels 
of truncated Isl1 proteins lacking either the LIM1 or LIM2 domain, or harboring only the Isl1 
homeodomain (Figure 2G, 2H). Furthermore, a truncated Ldb1 protein, lacking the LIM-
interaction domain (LID), responsible for the interaction of Isl1 with Ldb1, did not have an effect 
on Isl1 protein levels (Figure 2G). Co-immunoprecipitations using Isl1 deletion constructs 
revealed a critical role of the LIM1 domain of Isl1 in mediating the interaction with Ldb1 (Figure 
2I), corroborating previous findings (Jurata et al., 1996). Together these data suggest that the 
binding of Ldb1 to the LIM1 domain of Isl1 protects it from ubiquitination at the LIM2 domain and 
subsequently from proteasomal degradation (Figure 7E).  
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Ldb1 and Isl1 physically, functionally and genetically interact to regulate cardiac 
progenitor cell differentiation and heart development 
Ldb1 plays fundamental roles in development and cell differentiation as a cofactor for LIM-
domain proteins, suggesting that Ldb1 and Isl1 might functionally interact with each other during 
cardiogenesis.  To test this hypothesis, we first confirmed that Ldb1 and Isl1 interact in cardiac 
progenitor cells expressing endogenous levels of each protein by performing 
immunoprecipitation of Ldb1 from nuclear extracts of embryoid bodies (EBs) differentiated for 5 
days, a stage enriched in cardiac progenitors. We found that Ldb1 was efficiently co-
immunoprecipitated together with Isl1 (Figure 3A). Next, we transfected mouse ES cells with an 
expression plasmid carrying GFP alone or together with Isl1, Ldb1 or both Isl1 and Ldb1 (Figure 
S2A, S2B). GFP-expressing cells, isolated by FACS, were subjected to differentiation in EBs. 
Overexpression of Isl1 or Ldb1 alone significantly increased the percentage of beating EBs. 
Importantly, EBs differentiated from Isl1/Ldb1 overexpressing cells showed a higher number of 
beating foci compared to control EBs or EBs overexpressing Isl1 or Ldb1 alone, which had 
similar levels of Isl1 and Ldb1 compared to Isl1/Ldb1 overexpressing cells (Figure 3B, S2A, 
S2B). Consistently, the expression of the cardiomyocyte marker genes Mlc2a and Mlc2v was 
markedly increased and we observed a significant synergistic effect of Isl1 and Ldb1 on Mlc2a 
expression (Figure 3C). Furthermore, the expression of endothelial (Flk1, VE-Cad) and smooth 
muscle markers (SM-actin, SM-Mhc) was also increased (Figure 3D, 3E). Moreover, cardiac 
progenitor genes, which play key roles in SHF development (endogenous Isl1, Mef2c, Hand2 
and Fgf10) were significantly up-regulated (Figure 3F). Interestingly, overexpression of Ldb1 
significantly increased Flk-1+PDGFR-α+ cardiovascular progenitor numbers and the expression 
of Flk-1 and PDGFR-α (Figure 3G, Figure S2C), which may account for the increased 
expression of markers of all major cardiovascular lineages in Ldb1 and Isl1/Ldb1 overexpressing 
cells. Finally, we tested whether Isl1 and Ldb1 genetically interact during heart development. 
Crossing of Isl1 heterozygous and Ldb1 heterozygous mice revealed that only 5% of pups were 
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compound heterozygotes at the weaning stage, despite an expected ratio of 25%, whereas the 
other genotypes were recovered at similar percentages (Figure S2D). Timed mating revealed 
expected ratios of compound heterozygotes during mid to late gestation (Figure S2D), 
suggesting that the compound heterozygotes die after birth. Further histological analysis 
revealed that Isl1/Ldb1 double haplodeficient embryos had various heart abnormalities, including 
a small and thin right ventricle, ventricular septal defect (VSD), overriding aorta (OA) and double 
outlet right ventricle (DORV) (Figure 3H-K). To analyze the primary cause of the observed heart 
defects we microdissected the heart and the SHF from wt, Isl1+/-, Ldb1+/- and Isl1+/−Ldb1+/- 
E9.25 embryos. Importantly, real-time PCR analysis revealed significant downregulation of 
Hand2, Mef2c, Fgf10 and Mlc2v expression in Isl1/Ldb1 double haplodeficient embryos, 
supporting a key role of Isl1/Ldb1 complex in cardiomyocyte differentiation and Mef2c, Hand2 
and Fgf10 expression (Figure 3L).  
The dimerization domain of Ldb1 is required for SHF development and cardiac progenitor 
cell differentiation 
To further investigate the functions of Ldb1 during heart development, we ectopically 
overexpressed a truncated form of Ldb1 lacking the dimerization domain (DN-Ldb1, Figure 2G, 
Figure S3A), by injecting mRNA into one-cell stage embryos of the zebrafish transgenic line 
Tg(myl7:EGFP-HsHRAS)s883, which allows the easy monitoring of the cardiac morphology, 
through heart-specific expression of membrane-bound GFP (D'Amico et al., 2007). DN-Ldb1 
contains the highly conserved LIM-interaction domain (LID), which mediates high-affinity protein 
interactions with LIM domains, and can significantly stabilize Isl1 protein levels (Figure 2G,H), 
but lacks the dimerization domain, necessary to promote long range promoter-enhancer 
interactions. It has been previously shown that overexpression of this mutant protein results in a 
competition with wild-type Ldb molecules for binding to LIM domains of LIM-HD proteins, acting 
in a dominant negative manner (Bach et al., 1999; Becker et al., 2002). Consistently with 
previous studies, the overexpression of DN-Ldb1 led to defects in eye and brain development 
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(Figure S3B; (Becker et al., 2002)). Additionally, we observed that the heart contracted 
irregularly and with a reduced frequency (Figure S3C, S3D) in more than 80% of the embryos 
expressing DN-Ldb1. Furthermore the atrium of DN-Ldb1-expressing embryos was significantly 
shorter (Figure S3E). Interestingly, a similar phenotype was observed in isl1-mutant zebrafish 
embryos as a result of a failure of cardiomyocyte differentiation at the venous pole (de Pater et 
al., 2009). Confocal images of control and DN-Ldb1-expressing embryos stained with anti-Isl1 
antibodies at 48 hpf revealed dramatically less Isl1+ cardiomyocytes at the venous pole of the 
heart. In mutants, Isl1+ cells were found outside of the heart, but did not express the 
cardiomyocyte marker myl7, supporting a key role of Ldb1 dimerization in Isl1+ cardiomyocyte 
differentiation (Figure 4A). Consistent with this, bmp4 expression in the sinus venosus was 
strongly reduced in DN-Ldb1-expressing embryos, although bmp4 expression at the outflow pole 
and the atrioventricular canal was unaffected, in striking parallel to Isl1 mutant embryos (Figure 
4B). Additionally, the expression of mef2cb was also downregulated (Figure 4C). Since Isl1 
plays a key role in cardiac progenitor cells during development, we further addressed whether 
this phenotype can be attributed to defects at early stages of cardiogenesis by performing in situ 
hybridization and whole mount anti-Isl1 immunostaining of control and DN-Ldb1 overexpressing 
embryos at the 10 and 15 somites stage. No significant change of isl1 mRNA expression was 
detected, suggesting that Isl1+ progenitor cell numbers were not changed in DN-Ldb1 injected 
embryos (Figure 4D). However, Isl1 staining appeared to be stronger in the injected embryos, 
consistent with the stabilizing effect of DN-Ldb1 on Isl1 protein levels (Figure 4D, Figure 2). 
Importantly, we observed strong downregulation of hand2, mef2cb and nkx2-5, which play 
important roles in the SHF development (Figure 4D), whereas no change was observed in tbx5a 
expression. These findings suggest that not only the stabilization of Isl1 protein levels but also 
the formation of higher order complexes mediated by the Ldb1 dimerization domain might be 
important for proper cardiac progenitor cell differentiation during SHF development. To gain 
further support of this hypothesis, we generated stable Ldb1-deficient ES cell lines 
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overexpressing GFP alone, Isl1, Ldb1, DN-Ldb1 or in combinations. Consistent with an 
important role of Ldb1 in regulating Isl1 stability, Isl1 overexpressing Ldb1-/- ES cells showed 
dramatically lower Isl1 protein levels, compared to Ldb1-/- ES cells overexpressing Isl1 in 
combination with Ldb1 or the DN-Ldb1 (Figure S4A), although Isl1 mRNA levels were similar 
(Figure S4B). Importantly, Ldb1 overexpression led to a rescue of cardiac differentiation, as 
measured by the increased percent of beating EBs and mRNA levels of cardiomyocyte marker 
genes, Mlc2a, Mlc2v and Tnnt2 (Figure 4E, 4F). The functional rescue was further potentiated 
by overexpression of Isl1, confirming a synergistic role of these proteins in cardiomyocyte 
differentiation. By contrast, overexpression of DN-Ldb1 alone or in combination with Isl1 did not 
rescue the complete loss of cardiac differentiation of Ldb1-deficient EBs (Figure 4E, 4F). 
Furthermore, the expression of the endothelial marker genes CD31 and Flk1 was increased in 
Ldb1-/- EBs overexpressing Ldb1, whereas smooth muscle genes were decreased by Ldb1 
overexpression (Figure 4G), supporting a role of Ldb1 in the differentiation of cardiovascular 
progenitors into the cardiomyocyte and endothelial cell lineages and suppression of the smooth 
muscle lineage. FACS analysis for Flk-1 and PdgfR-α showed no significant differences in the 
Flk-1+PDGFR-α+ cardiovascular progenitor numbers upon Ldb1 and Isl1/Ldb1 overexpression in 
Ldb1-deficient EBs (Figure 4H), demonstrating that the dramatically increased cardiac 
differentiation is not due to an increased induction of cardiovascular progenitor cells. However, 
we observed a pronounced decrease of the Flk-1+/PdgfR-α+ population upon DN-Ldb1 
expression (Figure 4H). Interestingly this decrease was rescued by Isl1 overexpression in 
combination with DN-Ldb1 (Figure 4H), suggesting that the decrease in cardiovascular 
progenitor cells upon DN-Ldb1 overexpression might be due to interference with the function of 
LIM only or LIM-HD proteins. Furthermore, we saw rescue of Isl1+ cells and Isl1 expression 
upon Ldb1 and DN-Ldb1 expression (Figure 4I, Figure S4C), consistent with the role of Ldb1 
and DN-Ldb1 in stabilizing Isl1 protein levels, suggesting that the inability of DN-Ldb1 to rescue 
the cardiac differentiation defects of the Ldb1-deficient cells is not due to lack of Isl1+ cells. 
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Importantly, the expression of Mef2c and Hand2, factors crucial for SHF development and 
differentiation, was significantly upregulated upon Ldb1 overexpression but not upon 
overexpression of the DN-Ldb1 (Figure 4J). Isl1 has been shown to directly bind to the anterior 
heart field (AHF) enhancer, which directs the expression of Mef2c in the AHF (Dodou et al., 
2004, Witzel et al., 2012). Additionally, we found several conserved Isl1 consensus motifs 
(YTAATGR; TAAKKR (Mazzoni et al., 2013)) between -1,5kb and the Mef2c transcription start 
site (Figure S5). Chromatin immunoprecipitation (ChIP) analysis of nuclear extracts from day 5 
EBs demonstrated specific binding of Isl1 and Ldb1 to the conserved Isl1 binding sites (Figure 
4K). Moreover, ChIP experiments in pools of E8-9 embryos showed strong enrichment of Isl1 
and Ldb1 at these sites (Figure 4L). Additionally, we found Hand2 expression to be significantly 
altered upon loss and gain of function of Ldb1. Hand2 plays a key role in SHF development 
(Srivastava et al., 1997; Tsuchihashi et al., 2011), and its expression in the heart is specifically 
driven by a cardiac-specific enhancer located between -4.5 kb and -2.7 kb of the Hand2 
transcription start site (Figure S6; OFTRV enhancer) (McFadden et al., 2000). In silico analysis 
revealed several Isl1 consensus binding sites in the proximal promoter and the OFTRV 
enhancer of Hand2 (Figure S6). ChIP analysis of d5 EBs and E8-9 embryos showed strong 
binding of both Isl1 and Ldb1 at these sites (Figure 4M, 4N). Taken together, our data indicate 
that Mef2c and Hand2 are direct targets of the Isl1/Ldb1 transcriptional complex.  
Ldb1 facilitates long range enhancer-promoter interactions within the Hand2 and Mef2c 
loci 
Using chromosome conformation capture (3C) assays and 3C-based technologies (de Wit and 
de Laat, 2012; Dekker et al., 2002), it was shown that Ldb1 promotes chromatin looping events 
that bring distal enhancers into close proximity to promoters, thereby regulating gene expression 
(Deng et al., 2012; Morcillo et al., 1997; Soler et al., 2010; Song et al., 2007). To assess whether 
a similar mechanism controls cardiac progenitor cell gene expression gene expression, we 
analyzed whether binding of the Isl1/Ldb1 complex promotes chromatin loop formation at the 
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relatively small Hand2 locus. Using 3C-qPCR analysis with the Hand2 promoter as a viewpoint 
we observed a specific close proximity of the promoter with the OFTRV enhancer in d5 EBs from 
wild-type ES cells, but not in d5 EBs from Ldb1-deficient cells (Figure 5A). A similar interaction 
pattern was observed in Ldb1-/- EBs overexpressing Ldb1 and Isl1/Ldb1 but not in EBs 
overexpressing DN-Ldb1 or Isl1/DN-Ldb1 (Figure 5A, Figure S7A). No interaction was observed 
between the promoter and negative regions for Isl1 and Ldb1 binding located upstream of the 
OFTRV enhancer, between the promoter and OFTRV enhancer and downstream of the 
promoter. Further, no interaction was detected in wild-type and Ldb1-deficient ES cells, which do 
not express Isl1 (Figure 5A, Figure S7A).  
Next, to characterize the spatial interactions within the Mef2c locus we performed 3C-seq 
(Stadhouders et al., 2013), using two viewpoints: the Mef2c AHF enhancer, which drives Mef2c 
expression specifically in the AHF and the Mef2c promoter which drives Mef2c expression in 
different cell types. Multiple promoter-interacting elements were detected in the Mef2c locus, of 
which some showed a lower signal in Ldb1-deficient EBs (Figure 5B). Importantly, we observed 
interactions of the AHF enhancer with the promoter area and with the 3’ end of the Mef2c gene, 
which were decreased in Ldb1-deficient EBs (Figure 5B). 3C-qPCR experiments revealed a 
similar long-range interaction pattern in wild-type versus Ldb1-/- EBs during the course of 
cardiac differentiation, as well as from dissected SHF and hearts of E8-10.5 embryos, confirming 
the 3C-seq results (Figure 5C). Interestingly, we observed interactions of the AHF enhancer with 
the Mef2c proximal promoter co-occupied by Isl1 and Ldb1 in d4 EBs at the onset of Mef2c 
expression and in dissected SHF of E8.5 embryos, whereas in d5 EBs and dissected hearts 
from E9.5-10.5 embryos we observed strong interactions with regions more distal to the 
transcription start site (Figure 5C-D). Additionally, no interactions of the AHF enhancer with the 
promoter and with the 3’ end of the Mef2c gene was observed in the tail of the E8-9 embryos, 
suggesting that these chromatin loops are specifically formed in cardiac progenitor cells. 
Importantly, the 3C-seq signals correlated with the binding of Isl1 and Ldb1 at the Mef2c locus 
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(Figure S7B). Next, we sought to analyze whether the Ldb1 dimerization domain is required for 
chromatin loop formation by performing 3C-qPCR in d4 and d5 EBs from to Ldb1-/- ES cells 
overexpressing Isl1, Ldb1 and DN-Ldb1 alone or in combinations. Using the AHF enhancer as a 
viewpoint we observed a specific interaction of the AHF enhancer with the Mef2c promoter and 
the 3’ end of Mef2c gene in Ldb1-/- EBs overexpressing Ldb1 and Isl1/Ldb1, but observed no 
interaction of these genomic regions in Ldb1-/- EBs overexpressing DN-Ldb1 and Isl1/DN-Ldb1 
(Figure 5D). To analyze, whether the inability of DN-Ldb1 to promote loop formation was due to 
its inability to bind to the Isl1/Ldb1 binding sites we performed ChIP analysis of Ldb1-/- ES cells 
overexpressing Isl1 alone or in combinations with HA-Ldb1 or HA-DN-Ldb1 using anti-HA 
antibody. Importantly, we observed similar enrichment of Ldb1 and DN-Ldb1 at the Mef2c 
promoter and AHF enhancer, showing that the DN-Ldb1/Isl1 complex binds at its target sites, 
but cannot promote long-range promoter-enhancer interactions, necessary for proper gene 
regulation (Figure S7C). Finally, luciferase assays revealed significant synergistic effect of Isl1 
and Ldb1 on a luciferase construct containing the Mef2c promoter upstream and the Mef2c AHF 
enhancer downstream of a luciferase gene, in comparison to a reporter construct harboring the 
Mef2c promoter alone (Figure S7D), suggesting the requirement of Isl1/Ldb1 complexes in 
promoting long range promoter enhancer interactions to ensure high levels of heart specific 
Mef2c expression.  
To understand the functional significance of the dynamic chromatin looping at the Mef2c locus 
during the course of cardiac progenitor cell differentiation and heart development we analyzed 
the expression of annotated alternative Mef2c transcripts. Interestingly, while the longer 
reference sequence transcript (Refseq) was highly expressed in d4 EBs and in dissected SHF, 
the transcript with alternative transcriptional start site 1.5 kb downstream of the AHF enhancer 
was more abundant later during EB differentiation and in dissected hearts (Figure 5E), implying 
that the observed dynamic chromatin looping correlates with the expression of alternative 
transcripts for Mef2c. To better characterize the –14 kb to –5.5 kb genomic region found in close 
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proximity to the AHF enhancer we screened this region for known enhancer-associated 
chromatin marks H3K27ac, H3K4me1, p300 and Pol II. We found a marked enrichment of these 
marks -13 kb upstream of the TSS, which correlated with strong binding of Isl1 and Ldb1 at 
these sites (Figure 5F, Figure S7B). Sites within the –14 kb to –5.5 kb genomic region which 
were not bound by Isl1 and Ldb1 did not show significant enrichment of enhancer-associated 
chromatin marks (Figure 5F).  
Ldb1 orchestrate a network for transcriptional regulation and coordination in three-
dimensional space during cardiogenesis 
Gene Ontology (GO) analysis of sequences found by the 3C-seq in close proximity to the AHF 
enhancer over-represented in wild-type versus Ldb1-/- EBs, showed an enrichment of genes 
involved in heart development, cardiac muscle development, cell fate commitment and 
vasculature development within the first ten most enriched GO terms (Figure 6A, p<0.01). By 
contrast, when similar analysis was performed using the sequences found in proximity to the 
Mef2c promoter, no overrepresentation of GO terms involved in heart development was 
observed (Figure 6B). Importantly, we found that the AHF enhancer is involved in contacts with 
multiple genes, which play key roles during cardiac progenitor cell differentiation and heart 
development (Figure 6C, Table S1). 3C-qPCR analysis of wild-type versus Ldb1-/- EBs, as well 
as of dissected SHF or tails of E8-9 embryos confirmed the specificity and the Ldb1-dependence 
of these interactions (Figure 6D, 6E). Importantly, in d4 and d6 Ldb1-deficient EBs we observed 
significant downregulation of selected genes, which show significantly higher association with 
the AHF enhancer in wild-type versus Ldb1-/- EBs (Figure 7A). By contrast, genes which 
showed similar association with the AHF enhancer in wild-type and Ldb1-/- EBs (Rai2, Xrcc4), 
were not altered. Furthermore, overexpression of Isl1 and Ldb1, but not DN-Ldb1 strongly 
promoted the expression of the genes that were highly associated with the AHF enhancer in wild 
type EBs (Figure 7B). Moreover, we observed significant downregulation of these genes in 
hearts and dissected SHF regions of Isl1+/-Ldb1+/- E9.25 embryos compared to wild-type 
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embryos (Figure 7C, 7D). Taken together, these data provide strong support for a model 
according to which the Isl1/Ldb1-containing transcription complexes orchestrate a network for 
transcriptional regulation and coordination in three-dimensional space to regulate cardiac 
progenitor cell differentiation and heart development (Figure 7E).  
 
DISCUSSION 
The differentiation of cardiac progenitor cells into distinct lineages involves a coordinated series 
of large-scale transcriptional changes, but how these events are coordinated at the molecular 
level has remained poorly understood. Our study shows that a complex between the central SHF 
transcription factor Isl1 and the multi-adaptor protein Ldb1 plays a crucial role in directing 
chromatin organization and coordinating a cardiac lineage specific gene expression program.   
We found that Ldb1-deficient ES cells show a markedly decreased expression of SHF marker 
genes and subsequently impaired differentiation into the cardiomyocyte and endothelial 
lineages, while differentiation into the smooth muscle lineage was increased. Ldb1 gain-of-
function experiments confirmed the requirement of Ldb1 in the differentiation of cardiovascular 
progenitors in cardiomyocytes and endothelial cells and in suppressing the smooth muscle 
lineage. FACS analysis for Flk-1 and PdgfR-α and qPCR for Mesp1/2 revealed no significant 
differences in cardiovascular progenitor numbers upon Ldb1-deficiency, suggesting that Ldb1 
loss affects the differentiation of cardiovascular progenitor cells, but not cardiogenic cell-lineage 
commitment. Interestingly however, overexpression of Ldb1 in wild-type EBs significantly 
increased the number of Flk-1+PDGFR-α+ cardiovascular progenitors, suggesting that 
modulation of Ldb1 levels might affect cardiac lineage commitment. Consistent with this,  of DN-
Ldb1, which competes with full-length Ldbs for binding to LIM domain proteins led to a significant 
decrease in Flk-1+PdgfR-α+ cardiovascular progenitor cells, implying functional redundancy 
between Ldb1 and Ldb2 in cardiac lineage commitment. Mechanistically, we show that the 
importance of Ldb1 for cardiac differentiation and SHF development is two-fold (Figure 7E): (i) 
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Ldb1 binds to Isl1 and protects it from proteasomal degradation, as a consequence of which 
Ldb1-deficiency leads to an almost complete loss of Isl1+ cardiovascular progenitor cells. We 
found that Isl1 is ubiquitinylated at its LIM2 domain and via the binding of Ldb1, mainly to LIM1, 
Ldb1 protects Isl1 from degradation. This is consistent with previous studies, showing that LIM-
HD proteins levels are regulated by the proteasome and that binding of Ldb1 to LIM domain 
proteins protects them from degradation (Gungor et al., 2007). (ii) The Isl1/Ldb1 complex 
orchestrates a network for transcriptional regulation and coordination in three-dimensional space 
driving cardiac differentiation and heart development. A truncated Ldb1 protein (DN-Ldb1), 
which contains the LIM interaction domain and thereby can protect Isl1 protein from degradation, 
but lacks the dimerization domain and thus cannot promote long-range enhancer-promoter 
interactions (Krivega et al., 2014) did not collaborate with Isl1 to regulate the expression of their 
common targets and failed to rescue the cardiac differentiation defects of Ldb1-deficient cells 
(Figure 4E-F). Importantly, overexpression of DN-Ldb1 in zebrafish embryos leads to defects in 
the differentiation of Isl1+ cardiac progenitors at the venous pole in striking parallel with Isl1 
mutant fishes (de Pater et al., 2009), presumably by competing with full-length Ldb1 for binding 
to Isl1 (Bach et al., 1999). Importantly, upon overexpression of DN-Ldb1 we observed significant 
downregulation of hand2 and mef2cb, transcription factors which play important roles in 
cardiomyocyte differentiation and heart development (Lin et al., 1997; Srivastava et al., 1997; 
Tsuchihashi et al., 2011). Similarly, we observed decreased expression of Hand2 and Mef2c in 
Ldb1-deficient EBs, which showed complete blockade of cardiomyocyte differentiation, and in 
Isl1/Ldb1 haplodeficient embryos, which developed various cardiac anomalies. Moreover, our 
results suggest that the Isl1/Ldb1 complex directly regulates Mef2c and Hand2 expression by 
binding to their heart specific enhancers and stimulating promoter-enhancer interactions. 
Similarly, Ldb1 is required for the looping of the β-globin locus control region (LCR) to the β-
globin promoter (Deng et al., 2012; Song et al., 2007; Tolhuis et al., 2002), and it was shown 
that a fusion protein of LMO2 and the Ldb1 dimerization domain is sufficient to restore looping of 
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the β-globin promoter to the LCR and transcription in Ldb1 knockdown cells (Krivega et al., 
2014).  
Mef2c plays a key role in regulating anterior heart field development and cardiomyocyte 
differentiation. Similarly to Isl1, Mef2c-deficient hearts show outflow tract abnormalities and fail 
to form the right ventricle (Cai et al., 2003; Lin et al., 1997). 3C-seq and 3C-qPCR using the AHF 
enhancer of Mef2c, which confers responsiveness to Isl1 and GATA factors (Dodou et al., 2004), 
as a viewpoint identified close proximity between the promoter region, the AHF enhancer and 
the 3’ end of the gene. Gene looping has been shown to bring promoter and terminator regions 
together in close proximity in the early stages of transcriptional activation, facilitating RNA pol II 
re-initiation and high-level expression of the long genes FMP27 and SEN1 in Saccharomyces 
cerevisiae (O'Sullivan et al., 2004). Similarly, the observed loop between the promoter and the 
3’end of the Mef2c gene could generate a functional re-initiation complex for subsequent rounds 
of Mef2c transcription. Further, we observed dynamic chromatin looping at the Mef2c locus 
during heart development and in the course of cardiac progenitor cell differentiation, in which the 
AHF enhancer contacts the proximal promoter during the onset of Mef2c gene activation in the 
anterior heart field, whereas later this contact is lost, correlating with the expression of an 
alternative transcript with TSS 1.5 kb downstream of the AHF enhancer. A similar developmental 
switch in chromatin looping was observed during erythroid differentiation at the β-globin locus, 
from favoring the expression of embryonic globin genes in erythroid progenitors to favoring the 
expression of the adult globin genes in definitive erythrocytes (Palstra et al., 2003).  
Remarkably, our 3C-seq data identified surprisingly specific, Ldb1-mediated interactions of the 
AHF enhancer with multiple genes that play key roles in cardiovascular development, as well as 
cell fate commitment, suggesting a role of Ldb1 in regulating a cardiac-specific interaction 
network around the Mef2c AHF enhancer. These interactions are cell type specific, as they were 
observed in cardiac cells but not in other cells types, and are lost upon Ldb1-deficiency. Recent 
studies analyzing enhancer contacts during Drosophila development, revealed that a large 
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number of enhancer interactions are unchanged between different tissues and developmental 
stages and only few of them show significant changes (Ghavi-Helm et al., 2014). Notably, Ldb1 
appears to mediate cardiac cell-type specific chromatin loops and transcriptional programs, via 
its diverse DNA binding partners (Figure 5-7, (Soler et al., 2010; Song et al., 2007; Tolhuis et al., 
2002)). Importantly, Ldb1 deficiency led to dramatically decreased expression of the genes 
associated with the AHF enhancer and overexpression of Isl1 and Ldb1 strongly promoted their 
expression. The dosage-sensitive interdependence between Isl1 and Ldb1 in the expression of 
these key factors in cardiogenesis, further supports a key role of the Isl1/Ldb1 complex in 
coordinating chromatin looping and heart-specific gene expression. Notably, we observed 
significant enrichment for binding of the core cardiac transcription factors Gata-s, Nkx2-5, Mef2c 
and Tbx-s (Figure S7E) within the genomic regions found in close proximity to the Mef2c AHF 
enhancer. Interestingly, co-occupancy of these factors identifies transcriptional enhancers active 
in the heart (He et al., 2011) and their overexpression leads to a direct reprogramming of 
fibroblasts into functional cardiomyocytes, further supporting a role of cell type-specific 
transcription factor-regulatory networks in the control of cell type-specific genome organization 
and gene expression (de Wit et al., 2013; Denholtz et al., 2013).  
In conclusion, our study highlights a central role for Ldb1 in regulating cardiac progenitor cell 
differentiation and SHF development and provides exciting novel insights into the molecular 
machinery that orchestrates chromatin organization and coordinated gene expression during 
cardiogenesis. 
 
EXPERIMENTAL PROCEDURES 
Plasmids and Antibodies 
For detailed plasmid information, see the Supplemental Experimental Procedures. The following 
primary antibodies were used: rabbit anti-HA (Y-11; Santa Cruz Biotechnology), mouse anti-Flag 
(M2, Sigma), goat anti-Ldb1 (N-18, Santa Cruz Biotechnology), mouse anti-Ldb1 (C-9 Santa 
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Cruz Biotechnology),  mouse anti-Islet1 39.4D5 (Developmental Studies Hybridoma Bank); goat 
anti-Lamin B (C-20; Santa Cruz Biotechnology), mouse anti-tubulin (T5168 Sigma), anti-GFP 
(ab6556 Abcam), APC-conjugated anti-Flk1 (e-Bioscience 17-5821-81) and PE-conjugated anti-
PDGFRα (e-Bioscience 12-1401-81). 
Immunoprecipitation and ChIP 
Co-IPs and ChIP was performed as described in (Witzel et al., 2012). Detailed protocols are 
described in Supplemental Experimental Procedures. 
RNA Isolation, RT-PCR, and Real-Time PCR 
Embryos were dissected, and the SHF region and the heart were separately collected in cold 
PBS. RNA from EBs and embryos was isolated using Trizol (Invitrogen). cDNA was synthesized 
with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and real-time PCR 
was performed using the SYBR GREEN PCR master mix (Applied Biosystems) on Applied 
Biosystems StepOnePlusTM  real-time PCR detection system.  
Chromosome Conformation Capture Assays - 3C-seq and 3C-qPCR 
3C-seq and 3C-qPCR was performed as described in (Stadhouders et al., 2013). In brief, 1 × 
107 cells or dissected SHF regions or tails of 20 E8-9 embryos were crosslinked with 2% 
formaldehyde at room temperature for 10 min, followed by glycine quenching, cell lysis, HindIII 
(for 3C-seq and 3C-qPCR of the Mef2c locus) or NlaIII (or DpnII)  digestion (3C-qPCR of the 
Hand2 locus), and T4 ligation. As a positive control genomic DNA or bacterial artificial 
chromosomes (BAC) containing the entire Mef2c and Hand2 loci (Invitrogen) digested with 
HindIII or NlaIII (or DpnII) respectively were used, and religated to generate random ligation 
products. Primers sequences are listed in the Supplemental Experimental Procedures. 
Zebrafish strains 
Embryos and adult zebrafish were raised under standard laboratory conditions at 28 ºC. The 
following mutant and transgenic lines were used: Tg(myl7:EGFP-HsHRAS)s883 (D'Amico et al., 
2007) and  isl1sa0029 (Sanger Institute, Zebrafish Mutation Resource). 
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Mouse lines 
The Ldb1 tm1a(EUCOMM)Wtsi line was generated by microinjection of Ldb1 
tm1a(EUCOMM)Wtsi ES cells, obtained from the European Conditional Mouse Mutagenesis 
Program (EUCOMM), into blastocysts.  
mRNA injection 
mRNA synthesis was performed using mMESSAGE mMACHINE® SP6 Transcription Kit 
(Ambion) following manufacturer's instructions. mRNA was injected in 1- cell stage of fertilized 
zebrafish eggs (volume 2 nl, mRNA concentration 200 ng/µl for Flag-HA-DN-Ldb1).  
In situ hybridization, whole mount immunostaining and confocal microscopy 
In situ hybridization and whole-mount staining was performed as described (Witzel et al., 2012). 
Confocal images were acquired by a Zeiss LSM 710 system and the Z-stacks were projected by 
Zeiss LSM 710 software. 
Data deposition 
All sequencing data have been deposited in GEO (accession number SRP055800). 
 
SUPPLEMENTAL INFORMATION 
Supplemental Information includes Supplemental Experimental Procedures, seven figures and 
two tables. 
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FIGURE LEGENDS 
Figure 1. Ablation of Ldb1 results in defects in cardiac progenitor cell differentiation and 
SHF development. (A) Schematic diagram of the experimental setup. (B) Percentage of beating 
EBs in wild-type and Ldb1-/- ES cells differentiated in EBs. (C) Relative mRNA expression of 
cardiomyocyte (Mlc2a, Mlc2v, Tnnt2), endothelial (Flk1, CD31) and smooth muscle (SM-actin, 
SM-22) genes in d9 EBs differentiated from wild-type and Ldb1-/- ES cells. (D) Relative mRNA 
expression of mesodermal markers (Eomes, Bry, Mesp1 and Mesp2) in EBs differentiated from 
control and Ldb1-/- ES cells at different days. (E) Relative mRNA expression of cardiac 
progenitor marker genes in d4 EBs differentiated from Ldb1+/+ and Ldb1-/- ES cells. (F) Gross 
appearance of control (Isl1cre/+/Ldb1+/flox) and Isl1cre/+/Ldb1flox/flox embryos at E10.5, showing 
developmental arrest of the Ldb1-deficient embryos. Scale bars, 500 µm. (G) Higher 
magnification of E9.5 embryos viewed from the right (left panels) and the front (right panels), 
showing a short outflow tract and a small right ventricle. Scale bars, 200 µm. Abbreviations: 
OFT, outflow tract; RV, right ventricle; LV, left ventricle. (H) Relative mRNA expression analysis 
of cardiomyocyte genes in dissected outflow tract and right ventricle of E9.25 wild-type and 
Isl1cre/+/Ldb1flox/flox embryos. Data are mean ± SEMs, n=3 for each genotype. See also Figure S1. 
 
Figure 2. Ldb1 binds to Isl1 and protects it from proteasomal degradation. (A) FACS 
analysis of Flk-1 and PdgfR-α expression in d3.75 EBs differentiated from control and Ldb1-/- 
ES cells (B) Relative mRNA expression of Isl1 in EBs differentiated from control and Ldb1-/- ES 
cells at different days. (C) Isl1 immunostaining on vibratome sections from d5 EBs differentiated 
from control and Ldb1-/- ES cells. Scale bars, 100 µm. (D) Western blot analysis of total protein 
extracts of day 4, 5 and 6 EBs differentiated from control and Ldb1-/- ES cells. Lamin B1 served 
as loading control. (E) HA-tagged ubiquitin and Isl1 were transiently expressed in HEK293T 
cells. Cells were either treated with DMSO or with MG-132 6 h before harvesting. Equivalent 
amounts of total cellular protein were immunoprecipitated with an anti-Isl1 antibody. The co-
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immunoprecipitated proteins were detected by an immunoblot analysis with an anti-HA antibody. 
(F) Schematic representation of wild-type Isl1 and Isl1 deletion constructs, lacking either LIM1 or 
LIM2 or harboring only the homeodomain (top). Western blot analysis of whole cell lysates of 
HEK293T cells transfected with Isl1, Isl1LIM1, Isl1LIM2 and Isl1Homeo expression plasmids, 
treated with DMSO or MG-132. (G) Schematic representation of wild-type Ldb1 and Ldb1 
deletion constructs. Ldb1 harbors three domains that have been shown to be important for its 
function: dimerization domain (DD), the Ldb1/Chip conserved domain (LLCD) and the LIM-
interaction domain (LID) in the C-terminal part of the protein (top panel). HEK293T cells were 
transfected with constant amounts of Isl1 (10 µg) and GFP (1 µg, used as a control of 
transfection efficiency) expression plasmids and increasing amounts of Ldb1, Ldb1∆LID and 
DN-Ldb1 (5 and 9 µg). Immunoblot analysis of equal amounts of total protein extracts was 
performed using either anti-Isl1 or anti-GFP antibodies. (H) Western blot analysis of whole cell 
lysates from HEK293T cells transfected with Isl1, Isl1∆LIM1, Isl1∆LIM2 and Isl1HOMEO alone 
or together with DN-Ldb1 and GFP (internal control) using anti-Isl1, anti-FLAG and anti-GFP 
antibodies. (I) FLAG-HA-Ldb1 and Isl1 or Isl1 deletion constructs were transiently expressed in 
HEK293T cells and immunoprecipitation with an anti-Isl1 antibody was followed by immunoblot 
analysis with an anti-FLAG antibody. 
 
Figure 3. Ldb1 and Isl1 interact to regulate heart development. (A) Co-immunoprecipitation 
of nuclear extracts from d5 EBs using anti-Ldb1 antibody and detected with anti-Isl1 antibody. 
(B) Percentage of beating d7 EBs derived from ES cells overexpressing either GFP alone 
(control) or together with Isl1, Ldb1 or in combination. (C-E) Relative mRNA expression of 
cardiomyocyte (Mlc2a, Mlc2v) (C), endothelial (Flk1, VE-Cad) (D) and smooth muscle (SM-actin, 
SM-Mhc) marker genes (E) in d7 EBs differentiated from ES cells overexpressing either GFP 
alone (control) or together with Isl1, Ldb1 or Ldb1+Isl1. (F, G) Relative mRNA expression of 
cardiac progenitor marker genes in d4 EBs (F) and Flk1 and PdgfR-α in d3.75 EBs (G) 
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differentiated from ES cells overexpressing either GFP alone or together with Isl1, Ldb1 or 
Ldb1+Isl1. For qPCR analysis of endogenous Isl1 levels, primers located in the 5’UTR were 
utilized. Error bars represent SEMs derived from three biological replicates. (H-J) H&E staining 
of representative paraffin sections of E16.5 hearts of wild-type and Isl1+/-Ldb1+/- embryos (H, 
top panels), higher magnification of right and left ventricles showing thinner compact 
myocardium of the right ventricle in Isl1+/-Ldb1+/- embryos (H, bottom panels), DORV (I) or OA 
in E18.5 hearts (J) with VSD (I, J). Abbreviations: Ao, Aorta; LA, left atrium; LV, left ventricle; 
RA, right atrium; RV, right ventricle; DORV, double outlet right ventricle; OA, overriding aorta; 
VSD, ventricular septal defect. (K) Morphometric analysis of right ventricle compact myocardial 
thickness (n=4). (L) Relative mRNA expression analysis of cardiac progenitor and 
cardiomyocyte genes in dissected hearts and SHF of E9.25 wild-type, Isl1+/-, Ldb1+/- (controls) 
and double heterozygous Isl1+/-Ldb1+/- embryos. Data are mean ± SEMs, n=4 for each 
genotype. *p≤0.05, **p≤0.01, ***p≤0.005. See also Figure S2. 
 
Figure 4. The dimerization domain of Ldb1 is required for cardiomyocyte differentiation. 
(A) Confocal images of control and DN-Ldb1 overexpressing Tg(myl7:EGFP-HsHRAS)s883 
zebrafish embryos stained with anti-GFP and anti-Isl1 (red) antibodies at 48 hours post 
fertilization (hpf), showing shortened atrium and significant reduction of Isl1+ cardiomyocytes at 
the venous pole. Arrows indicate Isl1+ cells outside of the heart, which do not express the 
cardiomyocyte marker myl7. Scale bars, 50 µm. (B, C) In situ hybridization of control, DN-Ldb1 
overexpressing and Isl1 mutant embryos at 48 hpf with bmp4 (B) and mef2cb (C) probes. The 
arrows indicates bmp4 expression at the sinus venosus. (D) Confocal images of control and DN-
Ldb1 overexpressing embryos stained with anti-Isl1 antibody (leftmost panels) and in situ 
hybridization of control and DN-Ldb1 overexpressing embryos at 10-15s stages with isl1, nkx2.5, 
hand2, tbx5a and mef2cb probes. (E) Percentage of beating d7 EBs derived from Ldb1-/- ES 
cells overexpressing either GFP alone (control) or together with Isl1, Ldb1, DN-Ldb1 or in 
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different combinations. (F, G) Relative mRNA expression analysis of cardiomyocyte (F), smooth 
muscle and endothelial marker genes (G) in d7 EBs. (H) FACS analysis of Flk-1 and PdgfR-α 
expression in d3.75 EBs. (I) Western blot analysis of total protein extracts of d5 EBs. (J) Relative 
mRNA expression of Mef2c and Hand2 in d4 EBs. Error bars represent SEMs derived from three 
biological replicates. (K, L) ChIP of nuclear extracts from d5 EBs (K) and pools of dissected SHF 
from E8-E9 embryos (n=3) (L) using anti-Isl1 and anti-Ldb1 antibodies or IgG as control. PCRs 
were performed using primers flanking conserved Isl1 binding sites in the Mef2c promoter and 
the AHF enhancer. Fold enrichment values for EBs were calculated relative to IgG control and 
for embryos relative to a genomic region which does not contain conserved Isl1 binding sites. 
(M, N) ChIP of nuclear extracts from d5 EBs (M) and pools of dissected SHF from E8-E9 
embryos (N) using anti-Isl1 and anti-Ldb1 antibodies or IgG as a control. PCRs were performed 
using primers flanking conserved Isl1 binding sites in the Hand2 promoter and the OFTRV 
enhancer (McFadden et al., 2000). See also Figures S3-S7. 
 
Figure 5. Ldb1 facilitates long range enhancer-promoter interactions within the Hand2 
and Mef2c loci. (A) Schematic representation of the Hand2 genomic locus and the position of 
the DpnII restriction sites, used in the 3C assay (top). 3C-qPCR relative crosslinking frequency 
observed in WT, Ldb1-/- ES cells and d5 EBs derived from Ldb1-/- ES cells overexpressing 
either GFP alone or together with Isl1, Ldb1, DN-Ldb1 or in different combinations. The Hand2 
promoter was used as viewpoint to the Hand2 OFTRV enhancer or to negative control regions 
downstream of the Hand2 promoter, between the Hand2 promoter and the OFTRV enhancer 
and upstream of the OFTRV enhancer. Values were normalized to the-actin locus and the 
highest value for the OFTRV enhancer in d5 WT EBs was set as one. Data are mean ± SEMs, 
n=3. (B) Schematic representation of the Mef2c genomic locus and the position of the restriction 
sites of HindIII, used in the 3C assay (top). 3C‐Seq analysis of Mef2c AHF- (middle panel) and 
Mef2c promoter-associated regions (bottom panel) in d5 wild-type and Ldb1-/- EBs. The 
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viewpoint is indicated with an eye symbol. (C) 3C-qPCR relative crosslinking frequency 
observed in EBs at different days (top panels) and in microdissected SHF region, brain or tail 
from pools of embryos at different developmental stages (bottom panel). Data are mean ± 
SEMs, n=3. (D) 3C-qPCR relative crosslinking frequency observed in d4 (top) and d5 (bottom) 
EBs derived from WT and Ldb1-/- ES cells or Ldb1-/- ES cells overexpressing either GFP alone 
or together with Isl1, Ldb1, DN-Ldb1 in different combinations. Data are mean ± SEMs, n=3. For 
the 3C-qPCR in C and D the HindIII fragment containing the Mef2c-AHF was used as viewpoint 
(red bar, eye symbol). (E) Schematic representation of alternative Mef2c transcripts (top) and 
absolute quantification of these transcripts using primers indicated in the scheme (bottom). (F) 
ChIP of d4 EBs derived from WT and  Ldb1-/- ES cells using antibodies against H3, H3k4me1, 
H3K27Ac, p300, RNA-PolIIS5p and IgG as a control. (*p≤0.05, **p≤0.01, ***p≤0.005). See also 
Figure S7. 
 
Figure 6. Ldb1 promotes chromatin looping events between the AHF enhancer and genes 
which play key roles in cardiovascular development. (A, B) Gene ontology analysis of genes 
interacting with the Mef2c AHF (A) or the Mef2c promoter (B), overrepresented in wild-type 
versus Ldb1-/- cells. (C) Schematic representation of 3C-seq results showing specific 
interactions of the Mef2c AHF (located at chromosome 13 (Chr13)) with cardiac specific genes 
on Chr13 or on other chromosomes. The HindIII restriction sites are shown as black bars. Y 
axes - reads per million. (D, E) 3C-qPCR validation of the interactions observed using the 3C-
seq approach in WT or Ldb1-/- d5 EBs (D) or in microdissected SHF regions and tails of E8-9 
embryos (E) using the Mef2c-AHF as viewpoint. Data are mean ± SEMs, n=3. (*p≤0.05, 
**p≤0.01, ***p≤0.005). See also Figure S7. 
 
Figure 7. The Isl1/Ldb1 complex orchestrates a network for transcriptional regulation and 
coordination in three-dimensional space during cardiogenesis. (A) Relative mRNA 
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expression analysis in d4 and d6 WT and Ldb1-/- EBs of selected genes identified in the 3C-seq 
analysis to specifically interact with the Mef2c-AHF in WT but not in Ldb1-/- EBs. (B) Relative 
mRNA expression analysis of selected genes in d5 EBs overexpressing either GFP alone 
(control) or together with Isl1, Ldb1, DN-Ldb1 or in different combinations. (C-D) Relative mRNA 
expression analysis of selected genes in microdissected SHF (C) or heart (D) of WT or Isl1+/-
Ldb1+/- E9.25 embryos. Data are shown as mean ± SEMs, n=4. (*p≤0.05, **p≤0.01, 
***p≤0.005). (E) Model of the role of Ldb1 in heart development. Ldb1 binds to Isl1 and protects 
it from proteasomal degradation. The stabilized Isl1/Ldb1 complex orchestrates a network for 
transcriptional regulation and coordination in three-dimensional space during cardiac progenitor 
cell differentiation and heart development. 
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SUPPLEMENTAL FIGURES: 
Figure S1, related to Figure 1. Aberrant cardiac morphology in Isl1cre/+/Ldb1flox/flox embryos. 
(A) Left and right views of E9.5 control and Isl1cre/+/Ldb1flox/flox embryos after in situ hybridization 
with an Mlc2a riboprobe and corresponding sections, demonstrating aberrant cardiac 
morphology. Scale bars, 500 µm. Abbreviations: OFT, outflow tract; RV, right ventricle; LV, left 
ventricle. (B) Relative mRNA expression analysis of cardiomyocyte genes in dissected left 
ventricles of E9.25 control and Isl1cre/+/Ldb1flox/flox embryos. Data are mean ± SEMs, n=3 for each 
genotype.  
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Figure S2, related to Figure 3. Ldb1 and Isl1 interact to regulate heart development. (A) 
Relative mRNA expression of Ldb1 and Isl1 in ES cells overexpressing either GFP alone 
(control) or together with Isl1, Ldb1 or a combination of Isl1/Ldb1. (B) Western blot analysis of 
total protein extracts of ES cells overexpressing either GFP alone (control) or together with Isl1, 
Ldb1 or Ldb1+Isl1, using Isl1 antibody. Tubulin served as loading control. (C) FACS analysis of 
Flk-1 and PdgfR-α expression in d3.75 EBs differentiated from ES cells overexpressing either 
GFP alone (control) or together with Ldb1. (D) Analysis of the genotype of animals born from the 
cross Isl1+/- x Ldb1+/-. Total numbers (percentage) of recovered embryos or pups for all four 
different genotypes are shown. ***p<0,0001 Chi squared test.  
Figure S3, related to Figure 4. Cardiac morphogenesis defects in zebrafish embryos 
overexpressing DN-Ldb1. (A) Confocal images of control and FLAG-HA-DN-Ldb1 mRNA 
injected zebrafish embryos, stained with anti-FLAG antibody at 20 somites. (B) Control or DN-
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Ldb1 mRNA injected Tg(myl7:EGFP-HsHRAS)s883 embryos at 48 hpf. Lateral view, anterior to 
the left.  (C-D) Percentage of embryos with cardiac arrhythmia (C) and analysis of the number of 
heart beats per minute (D) measured at 24, 48 and 72 hpf in control and DN-Ldb1 
overexpressing zebrafish embryos. (E) Confocal images of control, DN-Ldb1 overexpressing 
and Isl1 mutant Tg(myl7:EGFP-HsHRAS)s883 hearts, showing shortening of the atrium (dotted 
lines) in DN-Ldb1 overexpressing and Isl1 mutant embryos. 
Figure S4, related to Figure 4. Overexpression of Ldb1 and DN-Ldb1 restores Isl1+ cells.  
(A) Western blot analysis of total protein extracts of Ldb1-/- ES cells overexpressing either GFP 
alone (control) or together with Isl1, Ldb1, DN-Ldb1 or in different combinations. (B) Relative 
mRNA expression of Ldb1 and Isl1 in Lbd1-/- ES cells overexpressing GFP, Isl1, Ldb1, DN-Ldb1 
or in different combinations. (C) Isl1 immunostaining on vibratome sections of d5 EBs 
differentiated from Ldb1-/- ES cells overexpressing either GFP alone (control) or together with 
Ldb1 and DN-Ldb1. Scale bars, 100 µm. 
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Figure S5, related to Figure 4 and 5. Alignment of conserved mouse and human 
sequences in the Mef2c locus, associated with the AHF enhancer. Consensus sites for Isl1 
are shown in yellow, for NKE in light blue and for GATA4 in light red. Primers used for ChIP or 
3C analysis are shown with grey boxes. HindIII restriction sites are shown in green.  
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Figure S6, related to Figure 4 and 5. Alignment of conserved mouse and human 
sequences in the Hand2 locus. Isl1 consensus sites are shown in yellow and GATA4 
consensus sites in light red. Primers used for ChIP or 3C analysis are shown as arrows above in 
grey boxes. NlaIII and DpnII restriction sites are shown in green and orange respectively. 
Abbreviations: TSS, transcription start site. 
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Figure S7, related to Figure 5 and Figure 6. Ldb1 promotes chromatin looping events 
between the AHF enhancer and genes which play key roles in cardiovascular 
development. (A) Schematic representation of the Hand2 genomic locus and the position of the 
NlaIII restriction sites, used in the 3C assay (top). 3C-qPCR analysis of WT, Ldb1-/- ES cells and 
d5 EBs derived from WT and  Ldb1-/- ES cells or Ldb1-/- ES cells overexpressing either GFP 
alone (control) or together with Isl1, Ldb1, DN-Ldb1, or in different combinations (bottom). (B) 
ChIP of nuclear extracts from d4 (left) and d5 (right) EBs using anti-Isl1 and anti-Ldb1 antibodies 
or IgG as a control. PCRs were performed using primers flanking conserved Isl1 binding sites 
(red) or not containing Isl1 consensus sites (light blue) in the -14 to -5.5 kb region within the 
Mef2c locus found by the 3C-seq in close proximity to the Mef2c-AHF. (C) ChIP of FLAG-HA-
Ldb1 and FLAG-HA-DN-Ldb1 or Isl1 in nuclear extracts from d4 EBs using anti-HA and anti-
Isl1antibodies. PCRs were performed using primers flanking the conserved Isl1 binding sites in 
the Mef2c promoter and the AHF enhancer. Fold enrichment values were calculated relative to 
the GFP control. (D) COS7 cells were transiently transfected with a 100 ng luciferase reporter 
construct containing the Mef2c promoter alone or in combination with the AHF enhancer, located 
downstream of the luciferase gene (Dodou et al., 2004), together with pcDNA (400 ng), Isl1 (400 
ng), Ldb1 (400 ng), DN-Ldb1 (400 ng)  or in combinations. The luciferase levels were normalized 
for the β-galactosidase activity of a cotransfected RSV-lacZ reporter (10 ng) and presented as 
fold activation relative to the luciferase levels of the reporter construct alone. All transfections 
were performed at least three times in triplicates, and representative experiments with the 
standard deviations are shown. See also Figure S3, S4 and S5. (*p≤0.05, **p≤0.01, ***p≤0.005). 
(F) Motif enriched in the genomic regions found in close proximity to the Mef2c AHF in d5 EBs. 
 
Table S1, Related to figure 6. Peak coordinates of sequences interacting with the Mef2c-
AHF and the Mef2c-promoter in d5 EBs. 
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Table S2. Synthetic oligonucleotides used in the study. 
Primers used for RT-PCR analysis: 
 
Primer Name Sequence 5’3’ Accession Number 
qGAPDH_for AACTTTGGCATTGTGGAAGG XM_001476707 
qGAPDH_rev GGATGCAGGGATGATGTTCT  
q5’UTRIsl1_for ACAGCACCAGCATCCTCTCT NM_021459 
q5’UTRIsl1_rev TCCCATCCCTAACAAAGCAC  
qIsl1_for GCGACATAGATCAGCCTGCT NM_021459 
qIsl1_rev GTGTATCTGGGAGCTGCGAG  
qLdb1_for GGGGGGTGGCAACACCAACAACA NM_001113408 
qLdb1_rev CCCCCACCACCATCACATCAGGT  
qNkx2.5_for AAGCAACAGCGGTACCTGTC NM_008700 
qNkx2.5_rev GCTGTCGCTTGCACTTGTAG  
qMef2c_for TCCATCAGCCATTTCAACAA NM_001170537 
qMef2c_rev AGTTACAGAGCCGAGGTGGA  
qTbx1_for CGACAAGCTGAAACTGACCA NM_011532 
qTbx1_rev AATCGGGGCTGATATCTGTG  
qTbx20_for GCAGCAGAGAACACCATCAA NM_020496 
qTbx20_rev GTGAGCATCCAGACTCGTCA  
qTbx5_for ATGGTCCGTAACTGGCAAAG NM_011537 
qTbx5_rev ACAAGTTGTCGCATCCAGTG  
qGATA4_for TCTCACTATGGGCACAGCAG NM_008092 
qGATA4_rev GCGATGTCTGAGTGACAGGA  
qHand1_for GCGGAAAAGGGAGTTGCCTCAGC NM_008213 
qHand1_rev GCTCCAGCGCCCAGACTTGC  
qHand2_for CGGAGAGGCGGAGGCCTTCA NM_010402 
qHand2_rev CAGGGCCCAGACGTGCTGTG  
qMlc2v_for CTGCCCTAGGACGAGTGAAC NM_010861 
qMlc2v_rev CCTCTCTGCTTGTGTGGTCA  
qMlc2a_for CCCATCAACTTCACCGTCTT NM_022879 
qMlc2a_rev CGTGGGTGATGATGTAGCAG  
qTnnt2_for ATCCCCGATGGAGAGAGAGT NM_011619 
qTnntt2_rev CTGTTCTCCTCCTCCTCACG  
qSM-actin_for CTGACAGAGGCACCACTGAA NM_007392 
qSM-actin_rev AGAGGCATAGAGGGACAGCA  
qSM-22a_for AACGACCAAGCCTTCTCTGCC NM_011526 
qSM-22a_rev TCGCTCCTCCAGCTCCTCGT  
qSM-mhc_for AGGAAACACCAAGGTCAAGCA NM_001161775 
qSM-mhc_for AGCCTCGTTTCCTCTCCTGA  
qBry_for AGGGAGACCCCACCGAACGC NM_009309 
qBry_rev CCGGGAACATCCTCCTGCCGTT  
qEoMes_for CAGGGCAGGCGCATGTTTCCT NM_010136 
qEoMes_rev TCCGCTTTGCCGCAGGTCAC  
qFlk1_for GGGTTTGGTTTTGGAAGGTT NM_010612 
qFlk1_rev AGGAGCAAGCTGCATCATTT  
qPDGFra_F GGAACCTCAGAGAGAATCGGC NM_001083316 
qPDGFra_R CATAGCTCCTGAGACCCGC  
qVE-Cad_for TGAGGCAATCAACTGTGCTC NM_009868 
qVE-Cad_rev TTCGTGGAGGAGCTGATCTT  
qIrx1_for CTTCTCGCAGATGGGCTCTC NM_010573 
qIrx1_rev TTCGTTGAGCCAGGCTTTCA  
qPitx2_for GTGGACCCTCTCGGAACTTG NM_001042504 
qPitx2_rev CTCCATTCCCGGTTATCGGC  
qMyocd_for GCTGAGACTCACCATGACAC NM_145136 
qMyocd_rev TGGACCTTTCAGTGGCGGTA  
qFoxC1_for CAACATCATGACGTCGCTGC   NM_008592 
qFoxC1_rev CTCTGGCCCGGAGAGTAGG    
qBmp2_for ATCACGAAGAAGCCGTGGAG NM_007553 
qBmp2_rev CTCGTCACTGGGGACAGAAC  
qBmpr2_for AGGTGGCCGAACAAATTCCA NM_007561 
qBmpr2_rev TCTTGTGTTGACTCACCTATCTGT  
qFgfr2_for CACGACCAAGAAGCCAGACT NM_010207 
qFgfr2_rev CTCGGCCGAAACTGTTACCT  
qSmad3_for AAGAAGCTCAAGAAGACGGGG NM_016769 
qSmad3_rev CAGTGACCTGGGGATGGTAAT  
qAcvr2a_for TCCTACTCAAGACCCAGGACC NM_007396 
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qAcvr2a_rev TCTGCCAGGACTGTTTGTCC  
qRyr2_for GACTGAGGAAGGATCAGGGGA NM_023868 
qRyr2_rev TTGTTGCCGGTCTGAGTTCT  
qKcnq1_for ACTTCACCGTCTTCCTCATTGT NM_008434 
qKcnq1_rev AGAGGCGGACCACATATTCTG  
qKcnj2_for TCTCACTTGCTTCGGCTCAT NM_008425 
qKcnj2_rev ACTTGTCCTGTTGCTGGTACA  
qFgf10_for TGCGGAGCTACAATCACCTC NM_00800 
qFgf10_rev GTTATCTCCAGGACACTGTACG  
qFgf8_for GCTGAGCTGCCTGCTGTT NM_010205 
qFgf8_rev GAGAGTGTCAGCTGGGTTCC  
qHDAC2_for CCCGTCAGCCCTCTTGTC NM_008229 
qHDAC2_rev TGCCAATATCACCATCATAGTAGT  
qRai_for CTTGGTGACAGCAGCGACAG NM_198409 
qRai2_rev CCACGTGGCCTCGGGAT  
qXrcc4_for GCAAACCACGGTATTAGCGG NM_028012 
qXrcc4_rev TGGCTACCTCTCAGTACTCCA  
Primers used for Mef2c isoforms absolute quantification 
 
Primer Name Sequence 5’3’  
Mef2cTotal_for ACGAGGATAATGGATGAGCGT  
Mef2cTotal _rev CAGCTTGTTGGTGCTGTTGAA  
Mef2cRefSeq_for GGCAAAGCTTCGGTGTTCAT  
Mef2cRefSeq _rev CTGCTGAGGGCTTTGTTGTC  
AK0077603_for GGTCAGCCTGTCCAAAAGGA  
AK0077603_rev ACAATGGATGTCAGTTGACCCA  
Primers used for ChIP  analysis 
Primer Name Sequence 5’3’ 
Mef2c-1,5Kb_for CTGATGGAGAGGTTGGGACT 
Mef2c-1,5Kb_rev ATGCAAGCACCTCTCTCACT 
Mef2c-1Kb_for CTGATGGAGAGGTTGGGACT 
Mef2c-1Kb_rev ATGCAAGCACCTCTCTCACT 
Mef2c-200bp_for GAATGGCAAATAACTACAGTGCT 
Mef2c-200bp_rev TCCTCATTTCACACAGGCTT 
Mef2c_AHF_for TCAGTGTCTGCTCCTGCTTC 
Mef2c_AHF_rev TTCCCTCCACACCTTACTGG 
Mef2c_-13Kb_for CTTGCAATTACTACCACTTCACA 
Mef2c_-13Kb_rev CCTTGTCTCAGTCCTGCTCA 
Mef2c+2,7Kb_for GGGGTGGGAATTTAATCA 
Mef2c+2,7Kb_rev GTCTGGTCAATGAGGAGGT 
Mef2c_+150Kb_for TCAAAGAAACTGAGCTACTGTCT 
Mef2c_+150Kb_rev GATGTCACACTAGATCCACAGT 
Mef2c_3’UTR_for CAGTGTCTGTCGTGCGTTTT 
Mef2c_3’UTR_rev ACCCAATTCACACCTTCCCA 
Mef2c_-9,6Kb_for AGTGAAGGAAGAAAAGGTGCA 
Mef2c_-9,6Kb_rev GCTGGCGTTTGTGTTCTCTT 
Mef2c_-12Kb_for ACCCAGAGACACAGGCATAA 
Mef2c_-12Kb_rev TTCCCTTTGCGGTTCCAATG 
Mef2c_-14Kb_for CTCAACTGGTGGTGTTAGC 
Mef2c_-14Kb_rev GCTCAACTGGTGGTGTTAGC 
Mef2c_-6,5Kb_for TGAGGTCCCATTTGTTGATGC 
Mef2c_-6,5Kb_rev TGTCCTCCCACAGTTCTTCA 
Mef2c_-7,5Kb_for TGTGTTCCATTCAGCAGAGG 
Mef2c_-7,5Kb_rev CCCCAAAGAACATGCATGGT 
Hand2_promoter_for TTCACCCCACCCCTGTAATC 
Hand2_promoter_rev AATTGCCGAGGTCCTCTTCT 
Hand2_OFTRV_for CTCAGAGCCAGCCAACTACT 
Hand2_OFTRV_rev TCACTCCTCACTGACAGCAC 
Actin_for GGAGCGGACACTGGCACAGC 
Actin_rev ATGCCCACACCGCGACCCTA 
Intergenic_for AAACCTCAAAGCCCAGGACACA 
Intergenic_rev ACTTGGTCCCGAGTTGATGGAA 
Primers used for 3C-seq Analysis 
Mef2cpromoter_F   ACACTTGTGCAGAGGGATC  
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Mef2cpromoter_R  AAGCTTTCTAATTTGGGAGC  
Mef2cAHF_F   TTAATTTATTACTAACATTGGAGGATC  
Mef2cAHF_R   AAGCTTGTGCTCTGTGACA 
Primers used for 3C-qPCR Analysis 
Primer Name Sequence 5‘3‘
3C_Mef2cAHF TTAATTTATTACTAACATTGGAGGATC  
3C_Mef2c prom GGGTCACACATCAAGGGTCT 
3C_Mef2c-13Kb CCTTGCCCAGAATGATCAGC 
3C_Mef2c+2,7Kb CCTTTGGCTCTCTCCTATCCT 
3C_Mef2c +150 GCAGAGATTAGCCAGTCTATGC 
3C_Mef2c 3’UTR CCAAGCCGCATATCTACTGC 
3C_Mef2c Negative TGTCTGACTCAGCTGTGGAG 
3C_Mef2c Negative2 
3C_Mef2c Negative3 
3C_Mef2C_Negative4  
3C_Mef2c Negative5  
ACCCAAGAAATTTTGAGAACCAA  
AACTGCAGCTTGTTTCACGT  
TAGGGGTGGCTTCTGGTTTT  
TGCTTTCCCACATTACTGAAGA  
3C_Ryr2 CAAATGTAGTGGTGGGTGCC 
3C_FoxC1 CAGCCCAAAGATGTTTCAGGT 
3C_Bmpr2 TGGATGAGTGGATGGGTAGA 
3C_Bmp2 CACACGCCATCACTTAGCAG 
3C_Fgf10 AGTGTTAGGATGCAGGGCTT 
3C_Acvr2a ACTCTGAAGGCTGGGAGTTC 
3C_Isl1 GCTTAAAGAGGCAGGCTCC 
3C_Smad3 AATATGTCCCAAATGTTTCACAGAA 
3C_Myocd CCACCATGGTCACTCTGTCC 
3C_Kcnq1 AGGAACCACTCTCCCAAAGG 
3C_Kcnj2 ACCGGTTAGCATGGTTTTAGC 
3C_Rai2 GAGAGGCTGGAGGGAAGAAA 
3C_Xrcc4 GGGTCCATGATTTGCCAAAGA 
3C_Hand2prom CGAGCGGCCCTAAAGATGTA 
3C_Hand2 OFTRV_NlaIII AAGCTTTAGACCCCTGGATTG 
3C_Hand2Negative1_NlaIII CTTCCCTGTCACATCACCCT 
3C_Hand2Negative2_NlaIII GCATTTCCAGCAAGCATCCT 
3C_Hand2Negative3_NlaIII CTTGTTTGGGGTGAGAAGGG 
3C_Hand2Negative4_NlaIII CACAGGGCAGTTAGGTCTCA 
3C_Hand2 OFTRV_DpnII TGTTGTTGTTGGTGGTGGTG 
3C_Hand2Negative1_DpnII CTAAGGGCTTCTGTTGACACC 
3C_Hand2Negative2_DpnII CCCATAGGCCTTGTTCTGGA 
3C_Hand2Negative3_DpnII CTAAGGTGGCTGGGACTAGG 
3C_Hand2Negative4_DpnII CGTGTGCTGTGTCTTCTCTT 
3C_Actin_F CTTCTGACCTAGAACTCTTGATCCC 
3C_Actin_R CCCTCTACACACACTCAGAATTCATC 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES: 
Plasmids: 
pcDNA3-Isl1, pcDNA3-Isl1∆LIM1, pcDNA3-Isl1∆LIM2, pcDNA3-Isl1HOMEO are described 
elsewhere (Witzel et al. 2012). 
Ldb1 and Ldb1 truncated proteins were amplified from mouse cDNA and cloned into the BamHI 
site of pcDNA3-Flag-HA vector. The following primers were used for amplification: 
Ldb1   Ldb1_F 5’ gatccatgtcagtgggctgtgcctgtcc 3’ 
 Ldb1_R 5’ ggatcctcactgggaagcctgtgacgtgg 3’  
Ldb1∆LID Ldb1_F 5’ ggatccatgtcagtgggctgtgcctgtcc 3’ 
  Ldb1∆LID_R 5’ ggatcctcagagagcgaaggtgctggctgggc 3’ 
DN-Ldb1 DN-Ldb1_F 5’ ggatccatggagcccgcacgacagcagcccag 3’ 
  Ldb1_R 5’ ggatcctcactgggaagcctgtgacgtgg 3’ 
The pCS2+Flag-HA-DN-Ldb1 plasmid was generated by subcloning the Flag-HA-DN-Ldb1 
HindIII - EcoRV insert of pcDNA3-Flag-HA-DN-Ldb1 in the blunted BamHI site of pCS2+. 
Lentiviral constructs were created by subcloning of the Flag-HA-Ldb1 or the Flag-HA-DN-Ldb1 
HindIII - EcoRV insert from pcDNA3 plasmids into the blunted BamHI site of pRRL.sin18-IRES-
GFP.  
Mef2c promoter and AHF enhancer were cloned from wild type mouse (C57BL/6) genomic DNA 
in pJet1.2 (Fermentas) and subsequently subcloned in pGL4-luciferase plasmid (Promega).  
The following primers were used for amplification: 
Mef2cpromoter_F 5’ gagctctcatactgaaagtgatttgac 3’ 
Mef2cpromoter_R 5’ agatcttctccccaccccaagcctct 3’ 
Mef2cAHF_F  5’ ggatcccattaaaatagtactctgca 3’ 
Mef2cAHF_R  5’ gtcgacgggccattaactttcgaatc 3’ 
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Cell Culture and Transfection 
HEK293T, and COS7 cells were grown in DMEM (Invitrogen) supplemented with 10% FBS 
(Invitrogen), 2mM L-Glutamine, 100U/ml Penicillin and 100 g/ml Streptomycin (Invitrogen) at 
37°C/5%CO2. Undifferentiated embryonic stem (ES) cells were maintained on mouse embryonic 
fibroblast (MEFs) feeder cells in DMEM supplemented with 15% fetal bovine serum (FBS, 
Invitrogen), 2 mM L-Glutamine,  0.1 mM 2-mercaptoethanol (Sigma), 0.1 mM non-essential 
amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 4.5 mg/ml D-glucose, and 1,000 
U/ml of leukemia inhibitory factor (LIF ESGRO, Millipore). To induce EB formation, dissociated 
ES cells were cultured in hanging drops of 500 cells per 15 μl of ES cell medium, in the absence 
of LIF. After 2 days in the hanging drop culture, the resulting EBs were transferred to bacterial 
culture dishes. For the transfection of HEK293T, cells were seeded at a density of 2.106 
cells/10cm dish and transfected with 10-20µg DNA using calcium phosphate precipitation. COS7 
were transfected using FuGENE® HD Transfection Reagent (Roche), according to the 
manufacturer instructions. For stable expression, ES cells were transduced with 
pRRL.Sin18.PGK-GFP-IRES (control construct) and pRRL.Sin18.PGK-GFP-IRES-Isl1, 
pRRL.Sin18.PGK-GFP-IRES-Ldb1, pRRL.Sin18.PGK-GFP-IRES-DN-Ldb1 or in combinations. 
Transduced cells were FACS sorted for GFP expression and used for EB differentiation. 
Luciferase Assay 
For Luciferase Assays, 3x104 COS7 cells were seeded in 24 well plates (details in Figure 6). 48h 
after transfection, cells were lysed in 100 µl lysis buffer (Promega, Luciferase Assay System) 
and luciferase activity was measured on Mirthras LB 940 (Berthold Technologies) according to 
the Luciferase Assay System Manual (Promega). β-galactosidase assays were performed using 
CPRG as substrate (Sigma).  
RNA Isolation 
RNA was isolated using the TRIzol Reagent (Invitrogen). cDNA was synthesized with the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems), and real-time PCR was 
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performed using the SYBR Green PCR Master Mix (Applied Biosystems). The cycle numbers 
were normalized to GAPDH (ES/EBs and Embryos). Primer pairs are described in Table S2.  
Immunofluorescence of Embryoid Bodies (EBs) 
EBs were collected, washed with PBS, embedded in 17% gelatin and fixed O/N at room 
temperature in 4% PFA. Next day the EBs were sectioned with vibratome at 70 µm. The 
obtained sections were fixed in 2% formaldehyde, 0.1M PIPES, 1.0 mM MgSO4, 2.0 mM EGTA 
O/N at 4°C, followed by 1 hour blocking (4% BSA + 0.4% Triton X-100) and incubated with 
primary and secondary antibodies diluted in blocking solution.  
Flow Cytometry 
For FACS analysis the EBs were dissociated, 1x106 cells were washed with 1 ml PBS and 
blocked in 100 µl FACS buffer (10% FCS in PBS) for 1 hour at room temperature. After blocking, 
the cells were stained with 0.5 µg each APC-conjugated anti-Flk1 (e-Bioscience 17-5821-81) 
and PE-conjugated anti-PDGFRα (e-Bioscience 12-1401-81) or control rat IgG2a K isotype 
APC- (e-Bioscience 17-4321) or PE-conjugated (e-Bioscience 12-4321) antibodies. After PBS 
washes, cells were fixed for 10 minutes at room temperature in 2% PFA. Data were acquired on 
an LSRII flow cytometer (BD) and analyzed using FlowJo software. 
Chromatin immunoprecipitation 
Embryoid bodies at day 4 or 5 of differentiation were dissociated with trypsin to obtain single 
cells suspension and resuspended with complete differentiation medium to obtain a 
concentration of 106 cells/ml. Cardiogenic region of 30 E8-9 embryos was dissociated with 
trypsin to obtain single cells, and resuspended in PBS containing 10% PBS. For chromatin 
immunoprecipitation 0.5 to 1x107 cells were fixed with 1% formaldehyde for 10 min. 
Formaldehyde was quenched with glycine at a final concentration of 125 mM and washed three 
times with PBS. Cells were lysed in L1 lysis buffer (50 mM Tris pH8, 2 mM EDTA pH8, 0.1% NP-
40, 10% glycerol) for 5 min, the nuclei were spun down and resuspended in L2 nuclear 
resuspension buffer (1% SDS, 5 mM EDTA pH8, 50 mM Tris pH8), followed by sonication to 
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fragment the chromatin. The samples were centrifuged, diluted 1:10 with DB-dilution buffer 
(0.5% NP-40, 200 mM NaCl, 5 mM EDTA, 50 mM Tris pH8) and incubated with primary antibody 
overnight at 4°C, followed by 3 h incubation with Protein-A/G Sepharose beads (GE Healthcare). 
Immunoprecipitates were washed two times with NaCl-washing buffer (0.1% SDS, NP-40 1%, 2 
mM EDTA, 500 mM NaCl, 20 mM Tris pH8), followed by two washes with LiCl-washing buffer 
(0.1% SDS, 1% NP-40, 2 mM EDTA, 500 mM LiCl, 20mM Tris pH8) and eluted with EB-
extraction buffer (TE pH8, 2% SDS). Cross-linking was reverted by overnight incubation at 65°C, 
DNA was purified and subjected to qPCR analysis. Primer pairs are described in Table S2. 
GO Analysis  
GO analysis was performed using DAVID software (Huang da et al., 2009a, b). 
Histological analysis 
Embryos were dissected in ice cold PBS, fixed in 4%PFA O/N at 4°C, dehydrated in Ethanol and 
stored at -20°C. For histological analysis, the tissues were incubated in 100% xylol and 
embedded in paraffin for further processing. Embedded organs were sectioned using an 
RM2245 microtome (Leica) and Hematoxilyn-Eosin (H&E) staining was performed. 
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